Srinivasan Charudharshini, Burgess Diane J
Department of Pharmaceutical Sciences, University of Connecticut, 69 North Eagleville Road, Unit 3092, Storrs, CT 06269, USA.
J Control Release. 2009 May 21;136(1):62-70. doi: 10.1016/j.jconrel.2009.01.022. Epub 2009 Feb 5.
Anionic lipoplexes, comprising divalent cations, DNA and anionic liposomes, were optimized for high transfection efficiency and low cytotoxicity. Different molar ratios of anionic to zwitterionic lipid, 1:9 to 1:1 (1,2-dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DOPG): 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), various cations (Ca2+, Mg2+ and Na+) and different anionic lipid/DNA ratios were investigated. The optimized formulation was composed of: anionic/zwitterionic lipid molar ratio 1:4 (DOPG:DOPE); 15-20 mM Ca2+; and 15-20 microg lipid for complexation with 0.8 microg plasmid DNA. Biophysical studies (particle size analysis, gel electrophoresis, transmission electron microscopy (TEM), and confocal microscopy) were conducted to characterize the different formulations. TEM revealed structural differences between the complexed and uncomplexed lipoplexes. Gel electrophoresis confirmed the formation of anionic lipoplexes with the amount of free DNA minimized for the optimized formulation. Confocal imaging showed cellular uptake of the anionic lipoplexes. Most significantly the anionic lipoplex formulation, optimized for the highest transfection efficiency (approximately 78% in the presence of serum) exhibited the highest cell viability (approximately 93%, (3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrazolium bromide) MTT assay). This was compared to Lipofectamine 2000 which had a transfection efficiency and cell viability of approximately 68% and 35%, respectively. The anionic lipoplex formulation developed here shows promise as a non-viral vector with high transfection efficiency and low cytotoxicity.
包含二价阳离子、DNA和阴离子脂质体的阴离子脂质复合物,针对高转染效率和低细胞毒性进行了优化。研究了阴离子与两性离子脂质的不同摩尔比(1:9至1:1,1,2 - 二油酰 - sn - 甘油 - 3 - [磷酸 - rac - (1 - 甘油)](DOPG):1,2 - 二油酰 - sn - 甘油 - 3 - 磷酸乙醇胺(DOPE))、各种阳离子(Ca2 +、Mg2 +和Na +)以及不同的阴离子脂质/DNA比例。优化后的配方包括:阴离子/两性离子脂质摩尔比为1:4(DOPG:DOPE);15 - 20 mM Ca2 +;以及15 - 20微克脂质用于与0.8微克质粒DNA复合。进行了生物物理研究(粒度分析、凝胶电泳、透射电子显微镜(TEM)和共聚焦显微镜)以表征不同的配方。TEM揭示了复合和未复合的脂质复合物之间的结构差异。凝胶电泳证实了阴离子脂质复合物的形成,对于优化后的配方,游离DNA的量降至最低。共聚焦成像显示了阴离子脂质复合物在细胞中的摄取。最显著的是,针对最高转染效率(在有血清存在的情况下约为78%)优化的阴离子脂质复合物配方表现出最高的细胞活力(约93%,(3 - [4,5 - 二甲基噻唑 - 2 - 基] - 2,5 - 二苯基溴化四氮唑)MTT法)。与之相比,Lipofectamine 2000的转染效率和细胞活力分别约为68%和35%。此处开发的阴离子脂质复合物配方有望成为一种具有高转染效率和低细胞毒性的非病毒载体。